{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:56:44Z","timestamp":1792169804376,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019718","name":"Boehringer Ingelheim Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim International GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.arbres.2022.05.002","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T03:33:47Z","timestamp":1652412827000},"page":"699-707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of Treatment With Dual Bronchodilation (LABA\/LAMA) Compared With Combination Therapy (LABA\/ICS) for Patients With COPD: A Population-Based Study"],"prefix":"10.1016","volume":"58","author":[{"given":"M\u00f2nica","family":"Monteagudo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexa","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Barrecheguren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2022.05.002_bib0170","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.chest.2018.02.023","article-title":"Considerations for the correct diagnosis of chronic obstructive pulmonary disease and its management with bronchodilators","volume":"154","author":"Anzueto","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2022.05.002_bib0175","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.chest.2016.02.646","article-title":"A systematic review with meta-analysis of dual bronchodilation with LAMA\/LABA for the treatment of stable COPD","volume":"149","author":"Calzetta","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2022.05.002_bib0180","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1517\/14656566.2015.1067682","article-title":"A re-evaluation of the role of inhaled corticosteroids in the management of patients with COPD","volume":"16","author":"D\u2019Urzo","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.arbres.2022.05.002_bib0185","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). 2019. Available from: https:\/\/goldcopd.org\/wp-content\/uploads\/2019\/11\/GOLD-2020-REPORT-ver1.0wms.pdf [cited 15.6.20]."},{"key":"10.1016\/j.arbres.2022.05.002_bib0190","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.arbres.2021.03.026","article-title":"Spanish COPD Guidelines (GesEPOC) 2021 updated pharmacological treatment of stable COPD","volume":"58","author":"Miravitlles","year":"2022","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.05.002_bib0195","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.200707-973OC","article-title":"The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol\/fluticasone propionate or tiotropium bromide","volume":"177","author":"Wedzicha","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.05.002_bib0200","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1056\/NEJMoa1516385","article-title":"Indacaterol-glycopyrronium versus salmeterol-fluticasone for COPD","volume":"374","author":"Wedzicha","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2022.05.002_bib0205","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1164\/rccm.201701-0193OC","article-title":"Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment data from the FLAME trial","volume":"195","author":"Roche","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.05.002_bib0210","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2022.05.002_bib0215","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1916046","article-title":"Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD","volume":"383","author":"Rabe","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2022.05.002_bib0220","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1007\/s12325-021-01646-5","article-title":"Effectiveness and safety of COPD maintenance therapy with tiotropium\/olodaterol versus LABA\/ICS in a US claims database","volume":"38","author":"Quint","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.arbres.2022.05.002_bib0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.arbres.2019.12.025","article-title":"Clinical management of COPD in a real-world setting. A big data analysis","volume":"57","author":"Izquierdo","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.05.002_bib0230","doi-asserted-by":"crossref","first-page":"992","DOI":"10.5588\/ijtld.15.0021","article-title":"Frequency and characteristics of different clinical phenotypes of COPD","volume":"19","author":"Miravitlles","year":"2015","journal-title":"Int J Tub Lung Dis"},{"key":"10.1016\/j.arbres.2022.05.002_bib0235","doi-asserted-by":"crossref","first-page":"210075","DOI":"10.1183\/16000617.0075-2021","article-title":"Systematic review on long-term adverse effects of inhaled corticosteroids in the treatment of COPD","volume":"30","author":"Miravitlles","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.arbres.2022.05.002_bib0240","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.medcli.2012.01.020","article-title":"SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research","volume":"138","author":"Bol\u00edbar","year":"2012","journal-title":"Med Clin"},{"key":"10.1016\/j.arbres.2022.05.002_bib0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rmed.2015.12.004","article-title":"Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study","volume":"11","author":"Barrecheguren","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.arbres.2022.05.002_bib0250","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.arbres.2020.07.032","article-title":"Treatment pathways before and after triple therapy in COPD: a population-based study in primary care in Spain","volume":"57","author":"Monteagudo","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.05.002_bib0255","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.arbres.2011.10.007","article-title":"Clinical phenotypes of COPD. Identification, definition and implications for guidelines","volume":"48","author":"Miravitlles","year":"2012","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.05.002_bib0260","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.arbres.2019.08.023","article-title":"Clinical characteristics and risk of exacerbations associated with different diagnostic criteria of asthma-COPD overlap","volume":"56","author":"Soler-Catalu\u00f1a","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.05.002_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15412555.2019.1575802","article-title":"Practical guide to the identification and diagnosis of asthma-COPD overlap (ACO)","volume":"16","author":"Nu\u00f1ez","year":"2019","journal-title":"COPD"},{"key":"10.1016\/j.arbres.2022.05.002_bib0270","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chest.2016.08.001","article-title":"Long-acting bronchodilator initiation in COPD and the risk of adverse cardiopulmonary events: a population-based comparative safety study","volume":"151","author":"Suissa","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2022.05.002_bib0275","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/EDE.0000000000000595","article-title":"A propensity-score-based fine stratification approach for confounding adjustment when exposure is infrequent","volume":"28","author":"Desai","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/j.arbres.2022.05.002_bib0280","first-page":"1015","article-title":"LANTERN: a randomized study of QVA149 versus salmeterol\/fluticasone combination in patients with COPD","volume":"10","author":"Zhong","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2022.05.002_bib0285","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1183\/13993003.00216-2016","article-title":"Efficacy and safety of aclidinium\/formoterol versus salmeterol\/fluticasone: a phase 3 COPD study","volume":"48","author":"Vogelmeier","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.05.002_bib0290","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/COPD.S95055","article-title":"The lung function profile of once-daily tiotropium and olodaterol via Respimat(\u00ae) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(\u00ae) (ENERGITO(\u00ae) study)","volume":"11","author":"Beeh","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2022.05.002_bib0295","doi-asserted-by":"crossref","first-page":"2000881","DOI":"10.1183\/13993003.00881-2020","article-title":"The right treatment for the right patient with COPD: lessons from the IMPACT trial","volume":"55","author":"Stolz","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.05.002_bib0300","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.arbres.2019.11.011","article-title":"The clinical implications of triple therapy in fixed-dose combination in COPD: from the trial to the patient","volume":"56","author":"L\u00f3pez-Campos","year":"2020","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.05.002_bib0305","doi-asserted-by":"crossref","first-page":"2003927","DOI":"10.1183\/13993003.03927-2020","article-title":"Heterogeneity within and between physician-diagnosed asthma and\/or COPD: NOVELTY cohort","volume":"58","author":"Reddel","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2022.05.002_bib0310","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.chest.2019.03.005","article-title":"Comparative effectiveness and safety of LABA-LAMA vs LABA-ICS treatment of COPD in real-world clinical practice","volume":"155","author":"Suissa","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2022.05.002_bib0315","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2147\/COPD.S204649","article-title":"Real-world effectiveness of umeclidinium\/vilanterol versus fluticasone propionate\/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study","volume":"14","author":"Moretz","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2022.05.002_bib0320","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.arbres.2019.12.015","article-title":"Blood eosinophil counts and their variability and risk of exacerbations in COPD: a population-based study","volume":"57","author":"Miravitlles","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2022.05.002_bib0325","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1164\/rccm.201912-2478OC","article-title":"The effect of inhaled corticosteroid withdrawal and baseline inhaled treatment on exacerbations in the IMPACT study. A randomized, double-blind, multicenter clinical trial","volume":"202","author":"Han","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2022.05.002_bib0330","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/COPD.S342220","article-title":"Inhaled corticosteroid use among COPD patients in primary care in Spain","volume":"17","author":"Miravitlles","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289622003374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289622003374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:41:31Z","timestamp":1759531291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289622003374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0300289622003374"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2022.05.002","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Treatment With Dual Bronchodilation (LABA\/LAMA) Compared With Combination Therapy (LABA\/ICS) for Patients With COPD: A Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2022.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}